At MS Paris 2017, Martin Weber, MD, of the University of Göttingen; Ruth Ann Marrie, MD, PhD, FRCP, of the University of Prof. John Corboy explains why Parkinson's Disease was chosen for World Brain Day 2020 Conversations on MS, August 25, 2023 live from Grand Junction, featuring Dr. John Corboy
Dr. Corboy will discuss new and evolving biomarkers that provide direction in determining individual treatment protocols, and also Lasting Legacy: Dr. John Corboy Reflects on More Than 30 Years of
John Corboy, MD, MA A CU Medicine provider. Multidisciplinary care for MS and related diseases. We believe in aggressive treatment of MS with disease Do DMTs do any good for people over 60? I was surprised to learn that there's actually a major study about that very question. John Corboy, MD, MA | Profiles | School of Medicine | University of
Welcome to a very special edition of Conversations on MS. This session features three MS-specialist neurologists answering At the Dedication of the Philip H. Corboy Center for Justice, Illinois Senate President John Cullerton talks about his first encounter
John M. Corboy, M.D. - Eye Mission of the Pacific Life and Times of Little Johnny Corboy
In multiple sclerosis (MS) treatment, the debate often surrounds the decision on which, and how to best use, disease-modifying John Corboy, MD: The Challenge of Doing Clinical Trials on Stopping DMTs in MS Conversations on MS with Dr. John Corboy, November 30, 2023
For son Matt. Dr. John Corboy is the founder of the Hawaiian Eye Foundation helping to promote eye health and restore the vision of impoverished people around the world. Investigating rebooting the immune system by using highly effective therapies is a novel approach currently under investigation for
Please take a look at a brief message from the Co-Directors of the Rocky Mountain MS Center at University of Colorado: Dr. For more Hot Topics on MedPage Today: What are the most Conversations on MS: Frequently Asked Questions
John Corboy, MD, a professor of neurology and the director of the Rocky Mountain MS Center at the University of Colorado, sat Illinois Gov. Pat Quinn speaks at the Renaming of the Illinois Trial Lawyers Association's headquarters after the late Phil Corboy,
Conversations on MS with Dr. John Corboy, recorded live in Grand Junction on Friday, August 23, 2024. TOPICS ADDRESSED IN Ask an MS Expert: How Aging Affects MS Dr. Corboy is also the founder of the Hawaiian Eye Foundation and the Eye Mission of the Pacific, which both provide philanthropic eye care
Can older MS patients safely stop taking their disease-modifying therapy? A Question and Answer session from the Rocky Mountain MS Center's Spring 2024 Education Summit, featuring Dr. John Corboy
Q&A session with Dr. John Corboy and Dr. Robert Gross. For complete information on the Education Summit, including a Discontinuing Disease Modifying Therapy Dr John Corboy on Probing Patient Quality of Life Off MS Medication
Conversations on MS with Dr. John Corboy, August 23, 2024 Free Eye Surgery Offered to Underinsured Residents
In last week's episode, we looked at talking with kids about MS. This week, we'll visit the opposite end of the spectrum as Dr. John MS Research Updates with Dr. John Corboy, Director of the Rocky Mountain MS Center at University of Colorado and Medical
Investigating rebooting the immune system by using highly effective therapies is a novel approach currently under investigation for patients with multiple The Future of Evidence Based Decisions in MS Treatment Q&A session from the Spring 2023 Education Summit, featuring Dr. John Corboy, Dr. Amanda Piquet, Dr. Enrique Alvarez, and Dr.
In this episode of Neurology Video Journal Club, Dr. Mark Burish, Associate Professor and Headache Specialist, Director, Will Physician Roll Call: Unmet Needs in Multiple Sclerosis
Patty Baskin and Dr John Corboy Introduce Neurology® Clinical Practice Publication Episode 255: Aging with MS with Dr. John Corboy
With the innovations in MS treatment in the last 75 years, people with MS are living longer than ever before. But how does aging Immunopathology changes with age, so for older individuals, we're going to need medications that focus on effects inside the Results of the DISCO-MS Trial with Dr. John Corboy
Some local doctors are offering free surgeries to help protect your eyes and vision. It's part of the 2nd Annual Cataract Days for The Rocky Mountain MS Center's latest webinar focused on COVID-19, featuring Dr. John Corboy, Co-Director of the RMMSC
Quality of life for patients with multiple sclerosis (MS) could be better when they are off medication because they will not have Hawaiian Eye Foundation's 2009 Tonga Expedition Our Founder: Dr. John Corboy | Hawaiian Eye Foundation
John Corboy, MD: The DISCO MS Trial Induction, Escalation, De-Escalation, Discontinuation: Treatment Decisions Over a Lifetime of MS
Conversations on MS with the MS Center's Dr. John Corboy, recorded on June 18, 2024. TOPICS ADDRESSED IN THIS Episode 392: From the 2025 ACTRIMS Forum with Dr. Lilyana Amezcua and Dr. John Corboy
Patty Baskin and Dr. John Corboy talk about Neurology® Clinical Practice. See for more information. Dr John Corboy: Why Disease-Modifying Therapy Efficacy Varies With Age
Beyond DISCO-MS: What Did We Learn? with Dr. John Corboy from the Rocky Mountain MS Center's Fall 2022 Education Dr. John Corboy's presentation at the Rocky Mountain MS Center Education Summit, May 16, 2020. To download a PDF version Detail of Multiple Sclerosis Studies, Clinic, Outcome Programs, Talk Around the World
The Rocky Mountain MS Center's Conversations on MS program, session recorded on August 25, 2023, live in Grand Junction, Presentation 6 of 6 Rocky Mountain Multiple Sclerosis Center's Scientific Advances in MS Research and Treatments seminar John M. Corboy grew up in Hawaii, attending first Punahou then St.Louis School. He completed his premedical training at Loyola University in Chicago and
In this webinar, Dr. John Corboy and Dr. Daniel Pastula discuss recently published data that shows an increased risk of severe John Corboy, MD: The Lack of Knowledge on Stopping DMT in MS and the DISCO-MS Trial Last week, 1800 scientists, clinicians, postdoctoral fellows, medical residents, and others arrived in West Palm Beach, Florida,
John Corboy, MD: Taking Patients Off Of Disease-Modifying Therapy Thanks to newer medications and treatment, people with MS are living longer than ever before. With longevity comes aging and
Dr. Corboy is also the founder of the Hawaiian Eye Foundation, which provided philanthropic eye care around the world for 40 years. TOPICS ADDRESSED IN THIS SESSION (click the timestamp to go to that point of the video) 3:47 BTK inhibitors 7:47 COVID-19 Update, DMT information, and Q&A: Oct. 29, 2020
John Corboy Medal | RACS Spring 2024 Education Summit: Q&A Panel #1 ACTRIMS 2025: Dr. John Corboy
Gov. Pat Quinn Talks about Legacy of Late Phil Corboy Hot Topics on MedPage Today: What is the role of MRI in both Dr. Daniel Kantor talks with Dr. John Corboy, Professor of Neurology at the University of Colorado School of Medicine about
What's the most underrecognized and undertreated aspect of MS? Spring 2022 Education Summit: General Questions and Answers Dr John Corboy Forecasts Promising Developments in Multiple Sclerosis
Have a look back at a special webinar with neurologist Dr. John Corboy as he shares the latest research updates in multiple Dr John Corboy (1969-2007) was elected chair of the RACS Trainees' Association in 2007. He was a great leader and a selfless representative of RACS Trainees In the last few decades, the number of multiple sclerosis therapies has grown exponentially, opening new doors to treatment and
John Corboy MD, MA | Neurology | UCHealth Dr John Corboy - DMT discontinuation and initiation in older patients with MS.
John Corboy, MD: The DISCO-MS Trial and Halting Disease-Modifying Therapy The accomplishments of Hawaiian Eye Foundations Tonga Expedition 2009 - Over 150 cataract and laser eye surgeries at Vaiola
Dr John Corboy - DMT discontinuation and initiation in older patients with MS Do patients with multiple sclerosis who have been on disease-modifying therapies (DMTs) for decades need to keep taking them?
Generics, Biosimilars, Dose Differences, Class Expansion, and Off-Label Medications in MS How Aging Affects MS
Patient-Centered Outcomes Research Institute (PCORI) DMT Discontinuation Trial John Corboy, MD, a professor of neurology and the co-director of the Rocky Mountain MS Program at the University of Colorado, Why Support the MS Center?
Question & Answer Session from the Spring 2023 Education Summit Established in memory of Dr John Corboy, who passed away while serving as Chair of the RACS Trainees' Association (RACSTA) and during his own surgical
A Great Phil Corboy Story Dr John Corboy Forecasts Promising Developments in Multiple Charles Elliot Morris Chair in Neurology · Executive Vice Chair of Neurology · Co-Director, Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus
Spring 2022 Education Summit: MS Research Updates Dr John Corboy
Dr. John Corboy is the Director of the Rocky Mountain MS Center at the University of Colorado, and he's also the principal Dr. Corboy has touched countless lives through his more than three decades serving people and their families living with MS in Colorado and beyond. Prof. John Corboy explains why Parkinson's Disease was chosen for World Brain Day 2020 and he explains his path in neurology
What is the role of MRI is both diagnosing MS and following the course of the disease? NVJC EP 37 Headache and Migraine:Sex Differences in Clinical Features, Treatment & Lifestyle Factors
Conversations on MS with Dr. John Corboy, June 18, 2024 Member Profile: John M. Corboy, MD - Hawaii Medical Association Webinar: DISCO-MS Extension Data and Other Key Updates in MS Research
Beta interferons in Multiple Sclerosis Dr. Jonathan Merril speaks with Dr. John Corboy about studies on discontinuing disease modifying therapies in Multiple Sclerosis.
Fall 2022 Education Summit: Beyond DISCO-MS: What Did We Learn? L2Talks - John Rinker Real Time Neurology's Daniel Kantor, MD interviews Tony Reder, MD, Professor of Neurology at the University of Chicago, about
West Nile Virus Disease: Effects of B Cell Depleting Therapies Dr. John Corboy's presentation from the Rocky Mountain MS Center's Spring 2024 Education Summit. The Education Summit was
Dr John Corboy on Research About Stopping DMTs for MS The DISCO-MS trial looked at the question "Can we define a population of patients in whom it's safe to discontinue their disease